Natriumklorid Fresenius Kabi 9 mg/ml infusionsvätska

DRUG4 trials

Sponsors

Rigshospitalet, Rigshospitalet, Rigshospitalet, Vaestra Goetalandsregionen, Region Skane

Conditions

InfectionST-segment myocardial infarctionSeriousStage IIb/c melanomachroniclife-limiting disease

Phase 2

Pulse Glucocorticoid Therapy In Patients With ST-Segment Elevation Myocardial Infarction (PULSE-MI)

RecruitingCTIS2022-500762-10-00

Rigshospitalet, RigshospitaletST-segment myocardial infarction

Start: 2022-11-14Target: 742Updated: 2023-04-14

Neoadjuvant pembrolizumab in patients with stage IIb/c melanoma, a phase II double-blind placebo-controlled randomized trial NEOPRIME

Not yet recruitingCTIS2024-519594-19-00

Vaestra GoetalandsregionenStage IIb/c melanoma

Target: 30Updated: 2025-06-19

Phase 3

Prophylactic treatment of breast implants with a solution of gentamicin, vancomycin and cefazolin antibiotics for women undergoing breast reconstructive surgery: a randomized controlled trial (The BREAST-AB trial)

RecruitingCTIS2024-517672-38-00

RigshospitaletInfection

Start: 2024-09-20Target: 1003Updated: 2025-10-28

Phase 4

Morphine for resting breathlessness in severe illness and palliative care (MORE-B): a randomized clinical trial

Not yet recruitingCTIS2026-525838-32-00

Region Skanechronic, life-limiting disease, Serious

Target: 40Updated: 2026-06-24

Related Papers

Pre-hospital pulse glucocorticoid therapy in patients with ST-segment elevation myocardial infarction transferred for primary percutaneous coronary intervention: a randomized controlled trial (PULSE-MI)

Trials2023-12-158 citations